Key points are not available for this paper at this time.
Cardiovascular diseases significantly burden healthcare systems globally, necessitating innovative solutions to enhance diagnosis, treatment, and patient management. Artificial intelligence (AI) is no longer a distant promise in interventional cardiology but a rapidly emerging tool with growing clinical impact. AI-driven technologies can analyze vast amounts of clinical data, recognize intricate patterns, and generate clinically relevant, evidence-based recommendations, augmenting physician expertise and streamlining care. In diagnostics, AI enhances imaging interpretation and lesion assessment, while procedurally, it supports real-time guidance and catheter-based interventions. Its integration into decision support systems has improved risk stratification, early disease detection, and individualized treatment planning. AI also advances personalized medicine using predictive models to tailor interventions to patient-specific needs. Despite its promise, challenges such as costs, ethical issues, and the need for rigorous validation remain barriers to widespread adoption. Nevertheless, as AI advances, its integration into interventional cardiology is expected to transform care delivery, optimize outcomes, and improve system efficiency.
Building similarity graph...
Analyzing shared references across papers
Loading...
Tochukwu Nzeako
Chukwuka Elendu
Gift Echefu
Annals of Medicine and Surgery
University of Tennessee Health Science Center
Trinity Health
Christiana Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Nzeako et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69ffcae97e61d2a3f0c22e6a — DOI: https://doi.org/10.1097/ms9.0000000000003602
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: